Dawn Health, a Danish HealthTech and healthcare SaaS provider operating in the UAE and Denmark, successfully raised $25 million in Series A funding to expand their MENA base.
The was led by a consortium of veteran investors including three Danish entities, namely Chr. Augustinus Fabrikker, Vaekstfonden - The Danish Growth Fund, and angel investor Lars Marcher.
Following the investment, Lars Marcher will assume the role as Chairman of the Board of Directors, accompanied by John Rubek Lauritsen from Chr. Augustinus Fabrikker and Mads Lacoppidan from the Danish Growth Fund.
Company: Dawn Health A/S.
Round: Series A
Funding Month: December 2021
Lead Investors: Chr. Augustinus Fabrikker, Vaekstfonden and Lars Marcher
Company Website: https://dawnhealth.com/
Software Category: life-changing digital health software products
About the Company: Launched in 2016, Dawn Health has established a unique process landscape and certified quality management system that allows for the agile development of highly regulated software products. This capability has fueled rapid growth and caries the potential to make Dawn Health a global leader in the development of life-changing digital health software products targeting patients with chronic diseases. Dawn Health’s mission is to develop empathetic and intuitive digital health products with the ultimate goal of helping people live longer, healthier, and better lives.